Information for investors

Important information
Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following and confirm your country of residence. Your confirmation must be true and accurate.Please enter your country of residence:


The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.

The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.

The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.

The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.

The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.


The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States. The documents related to the offering, including the Finnish-language prospectus in accordance with the Finnish Securities Markets Act, may not be delivered to the above-mentioned countries and may not be copied in any way whatsoever. FIT Biotech (the “Company”) requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion, reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.

This website and the information contained herein are not intended for, and must not be accessed by, or distributed or disseminated to, persons resident or physically present in Australia, Canada, Hong Kong, Japan, South Africa or the United States, and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any shares, rights or other securities of FIT Biotech Ltd (the “Company”) in Australia, Canada, Hong Kong, Japan, South Africa or the United States.The offering shall be governed by the laws of Finland. No action has been taken, except solely in Finland, in order to register the offer shares or the offering or for the public offering of the offer shares. The offer shares may not be, directly or indirectly, offered, sold, resold, transferred or delivered in such countries or jurisdictions or otherwise in such circumstances in which it would be unlawful or require measures other than those required under Finnish laws, including Australia, Canada, Hong Kong, Japan, South Africa and the United States.Neither the documents on this website nor the Finnish-language prospectus prepared in accordance with the Finnish Securities Markets Act may be delivered to persons in the above-mentioned countries, nor may such materials be copied in any way whatsoever. The Company requires that the respective persons inform themselves of and observe all such restrictions. Neither the Company nor the Company’s representatives have any kind of legal responsibility for such violations whether or not such restrictions were known to prospective investors. The Company reserves the right to, in its sole discretion reject any type of offer share subscription that the Company believes would cause the violation or breach of legislation, rule or regulation.In order to access the information related to the offering, you must certify the following:I have carefully read and understood the instructions and restrictions described above and I acknowledge that they are applicable to me.I am not resident of Australia, Canada, Hong Kong, Japan, South Africa or the United States and I am cur-rently not physically present in any of these countries.If I am resident of any other country than Finland or if I am currently physically present in any country other than in Finland, I have obtained the necessary information about the restrictions applicable to the delivery of this information and my participation in the offering and I acknowledge that they are applicable to me.

I Agree >

I Disagree ->